Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma

We conducted a prospective, three-center, observational study in Japan to evaluate the prevalence of seropositivity and clinically protective titer after coronavirus disease 2019 vaccination in patients with plasma cell dyscrasia(PCD). Two-hundred sixty-nine patients with PCD [206 symptomatic multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Terao, Toshiki, Yamashita, Takeshi, Fukumoto, Ami, Kamura, Yuya, Ikeda, Daisuke, Kuzume, Ayumi, Tabata, Rikako, Tsushima, Takafumi, Miura, Daisuke, Narita, Kentaro, Takeuchi, Masami, Doi, Masahiro, Umezawa, Yuka, Otsuka, Yoshihito, Takamatsu, Hiroyuki, Matsue, Kosei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860256/
https://www.ncbi.nlm.nih.gov/pubmed/35190963
http://dx.doi.org/10.1007/s12185-022-03300-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860256/
https://www.ncbi.nlm.nih.gov/pubmed/35190963
http://dx.doi.org/10.1007/s12185-022-03300-4

Ejemplares similares